ID

15787

Descripción

Principal Investigator: Luisa Klotz Collaborator: Novartis Information provided by (Responsible Party):University Hospital Muenster -Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya (ToFingo2) Purpose A trial in patients with relapsing remitting multiple sclerosis (RRMS) Main objectives: •To evaluate changes in the reconstitution of immune surveillance over time upon switching from natalizumab to fingolimod assessed by a change in the expression of CD49d. •To evaluate changes in the migratory capacity of immune cells/peripheral blood mononuclear cells (PBMCs) upon switching from natalizumab to fingolimod in an in-vitro model of the blood-brain-barrier (BBB). •To evaluate changes in paraclinical disease activity over time upon switching from natalizumab to fingolimod assessed by MRI (changes in Gd+, T2w lesions and DTI). •To evaluate changes in T1w / FLAIR lesions upon switching from natalizumab to fingolimod. For further Information please visit https://clinicaltrials.gov/ct2/show/NCT02325440

Link

https://clinicaltrials.gov/ct2/show/NCT02325440

Palabras clave

Versiones (2)
  1. 1/6/16 1/6/16 -
  2. 13/6/16 13/6/16 -
Subido en

13 de junio de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

ToFingo Screening V1 Previous and concomitant medication non drug therapies NCT02325440

Inglés

ToFingo Screening V1 Previous and concomitant medication non drug therapies NCT02325440

1 formularios  
Study administration
Descripción

Study administration

Data entry for this CRF completed
Descripción

Data entry for this CRF completed

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3899518
Assessment date
Descripción

Assessment Date

Tipo de datos

date

Alias
UMLS CUI [1]
C0011008
Current patient (ID)
Descripción

Current patient (ID)

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Previous and concomitant medication
Descripción

Previous and concomitant medication

Alias
UMLS CUI-1
C0033045
Medication/non-drug therapy
Descripción

Medication/non-drug therapy

Tipo de datos

integer

Alias
UMLS CUI [1]
C0013227
Start date of therapy
Descripción

Start date of therapy

Tipo de datos

date

Alias
UMLS CUI [1]
C1707481
End date of therapy
Descripción

End date of therapy

Tipo de datos

date

Alias
UMLS CUI [1]
C1707480
Single dose/Unit
Descripción

Single dose/Unit

Tipo de datos

float

Unidades de medida
  • mg
Alias
UMLS CUI [1]
C1960417
mg
Amount/Unit
Descripción

Amount/Unit

Tipo de datos

integer

Frequency/Unit
Descripción

Frequency/Unit

Tipo de datos

integer

Alias
UMLS CUI [1]
C3476109
Volver a la parte superior de la página

Similar models

ToFingo Screening V1 Previous and concomitant medication non drug therapies NCT02325440

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Study administration
Data entry for this CRF completed
Item
Data entry for this CRF completed
boolean
C3899518 (UMLS CUI [1])
Assessment Date
Item
Assessment date
date
C0011008 (UMLS CUI [1])
Current patient (ID)
Item
Current patient (ID)
text
C2348585 (UMLS CUI [1])
Item Group
Previous and concomitant medication
C0033045 (UMLS CUI-1)
Medication/non-drug therapy
Item
Medication/non-drug therapy
integer
C0013227 (UMLS CUI [1])
Start date of therapy
Item
Start date of therapy
date
C1707481 (UMLS CUI [1])
End date of therapy
Item
End date of therapy
date
C1707480 (UMLS CUI [1])
Single dose/Unit
Item
Single dose/Unit
float
C1960417 (UMLS CUI [1])
Amount/Unit
Item
Amount/Unit
integer
Frequency/Unit
Item
Frequency/Unit
integer
C3476109 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial